CCL8 recruits monocytes, induces CSF-1 production to maintain TAM survival and proliferation, and binds SIGLEC1 to enhance tumor cell motility; inhibition of the CSF-1/CSF-1 receptor axis reduces angiogenesis. The gene discussed is CSF1; the disease is neoplasm.